user

GENETIC TESTING OF FAMILIAL HYPERCHOLESTEROLEMIA: MONOGENIC FORM AND POLYGENIC CONTRIBUTION TO CARDIOVASCULAR RISK

被引：0
|
作者：
Couvert, Philippe [1 ,2 ,3 ,4 ]
Giral, Philippe [1 ,2 ,3 ,5 ]
Boelle, Pierre-Yves [6 ,7 ]
Carreau, Valerie [1 ,2 ,3 ,5 ]
Beliard, Sophie [8 ]
Lacorte, Jean-Marc [1 ,2 ,3 ,4 ]
Lesnik, Philippe [1 ,2 ,3 ]
Paillard, Francois [9 ]
Valero, Rene [8 ]
Rotthier, Annelies [10 ]
Bruckert, Eric [1 ,2 ,3 ,5 ]
Carrie, Alain [1 ,2 ,3 ,4 ]
机构：
[1] INSERM Unite Mixte Rech S 1166, Paris, France
[2] Univ Paris 06, Paris, France
[3] Inst Cardiometab & Nutr, Paris, France
[4] Hop La Pitie Salpetriere, AP HP, Serv Biochim Endocrinienne & Oncol, Paris, France
[5] Hop La Pitie Salpetriere, AP HP, Serv Endocrinol Metab, Paris, France
[6] IPLESP, INSERM E1 U1136, Paris, France
[7] Hop St Antoine, AP HP, Biostat & Sante Publ, Paris, France
[8] Aix Marseille Univ, Fac Med, UMR INSERM INRA 1062 1260, Marseille, France
[9] CHU Pontchaillou, Ctr Prevent Cardiovasc, Rennes, France
[10] Multiplicom NV Galileilaan, Niel, Belgium
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.304
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG176
引用
收藏
页码：E94 / E94
页数：1
相关论文
共 50 条
  • [1] MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA, POLYGENIC HYPERCHOLESTEROLEMIA, AND THE RISK OF PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Trinder, M.
    Li, X.
    DeCastro, M. L.
    Cermakova, L.
    Sadananda, S.
    Jackson, L.
    Azizi, H.
    Mancini, G. B. J.
    Francis, G.
    Frohlich, J.
    Brunham, L.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E91 - E91
  • [2] Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
    Trinder, Mark
    Paquette, Martine
    Cermakova, Lubomira
    Ban, Matthew R.
    Hegele, Robert A.
    Baass, Alexis
    Brunham, Liam R.
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (05): : 515 - 523
  • [3] MONOGENIC VERSUS POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA: GENETIC RISK SCORE AND RESPONSE TO TREATMENT
    Minicocci, I.
    D'Erasmo, L.
    Di Costanzo, A.
    Pigna, G.
    Commodari, D.
    Ceci, F.
    Montali, A.
    Maranghi, M.
    Arca, M.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E25 - E26
  • [4] CARDIOVASCULAR RISK OF MONOGENIC VERSUS POLYGENIC CAUSES OF HYPERCHOLESTEROLEMIA
    Brunham, Liam
    Francis, Gordon
    Trinder, Mark
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1834 - 1834
  • [5] FAMILIAL HYPERCHOLESTEROLEMIA - MONOGENIC, POLYGENIC OR BOTH?
    Medeiros, Ana Margarida
    Alves, Ana Catarina
    Chora, Joana Rita
    Bourbon, Mafalda
    [J]. MEDICINE, 2022, 101 (30)
  • [6] Monogenic, polygenic, and oligogenic familial hypercholesterolemia
    Tada, Hayato
    Nohara, Atsushi
    Kawashiri, Masa-aki
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (04) : 300 - 306
  • [7] Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts, Julia
    Dharmayat, Kanika, I
    Ray, Kausik K.
    Vallejo-Vaz, Antonio J.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (03) : 111 - 118
  • [8] Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
    Trinder, Mark
    Francis, Gordon A.
    Brunham, Liam R.
    [J]. JAMA CARDIOLOGY, 2020, 5 (04) : 390 - 399
  • [9] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Jacob, Erin
    Hegele, Robert A.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 419 - 426
  • [10] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Erin Jacob
    Robert A. Hegele
    [J]. Current Atherosclerosis Reports, 2022, 24 : 419 - 426
12345